The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
With a RM7.9 billion allocation, Malaysia is pivoting toward TVET and STEM to build the high-skilled workforce required to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback